Students Invent/Market Nosebleed Device
Imagine waking up in the wee hours of the morning to your child standing beside your bed with a bloody nose, or leaving a movie early because your nose is bleeding, or even heading to the emergency room to have your child’s nose cauterized.
Nosebleeds are startling, messy and time-consuming, but they’re not just an inconvenience, they’re expensive. Currently, one in every 200 emergency room visits is for a nosebleed, with an estimated 700,000 cases annually.
Jacob Hess BS ’18, Kortney James and Dalton Facer BS ’17 have a solution. Together, the three created and marketed Rhinostasis, an innovative, cost-effective product to stop out-of-control nosebleeds. Hess, a biochemistry and pre-medical graduate; James, who is pursuing a post-bachelor’s degree enhancement in microbiology; and Facer, an economics and entrepreneurship graduate, have already secured one patent for the product and are working toward Food and Drug Administration approval before going commercial.
“Rhinostasis will pre-treat cotton inserts with a safe medicine that helps clot blood and prevent future bleeding,” Hess said. “The inserts could be used by medical professionals or people at home.”
The product has earned several kudos already, winning WSU’s 2018 Opportunity Quest and an annual business plan competition between WSU and Shanghai Normal University (SHNU) in China.